NCT01145950View on ClinicalTrials.gov

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

January 31, 2011

Conditions

Healthy

Interventions

DRUG

LBEC0101

Etanercept 25mg, single dose

DRUG

Enbrel

Etanercept 25mg, single dose

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY